Taken together, these findings indicate that both quantitative and qualitative losses of FUS function are likely involved in the pathogenesis of FTLD/ALS, and should provide clues for therapeutics that clarify the functional properties of FUS. This evidence concerns the gene FUS and amyotrophic lateral sclerosis.